Trial intelligence / Profile preview

Remimazolam + propofol vs propofol alone in elderly VATS lobectomy

ChiCTR2400090637Phase 4Completed

Sponsor
Liaoning Province Cancer Hospital
Start
Oct 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of remimazolam and propofol in bronchial carcinoma (3 arms), sponsored by Liaoning Province Cancer Hospital. Primary endpoint: Incidence of intraoperative hypotension. Started Oct 2024; status: completed.

02

Drugs

remimazolampropofol
03

Conditions

bronchial carcinoma

Beyond the preview

Go deeper on ChiCTR2400090637.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2400090637.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call